Literature DB >> 417883

Evaluation of the results of trans-sphenoidal surgery in acromegaly by assessment of the growth hormone response to thyrotrophin-releasing hormone.

G Faglia, A Paracchi, C Ferrari, P Beck-Peccoz.   

Abstract

Eighteen acromegalic patients GH-responsive to TRH were reinvestigated following trans-sphenoidal surgery and radiotherapy. Basal serum GH decreased below 10 microgram/1 in thirteen cases; nine of them became GH-unresponsive to TRH 1 month after operation, and another one following conventional pituitary irradiation. Four of these ten patients also showed a normal GH response to L-Dopa after treatment, and five responded normally to insulin-induced hypoglycaemia; two patients had a normal GH secretory pattern after both these stimuli. No recurrences were observed over a follow-up period of 15-80 months among the ten patients who became GH-unresponsive to TRH following operation, while one of the three subjects still responsive to TRH in spite of normalized basal serum GH concentration relapsed 10 months after surgery. Three patients with normalized TRH test following operation were repeatedly reinvestigated over a 3-6 years period and always found unresponsive. The present study shows that the 'paradoxical' GH responses to TRH and L-Dopa frequently disappear after surgery, that complete normalization of GH secretory pattern may rarely be attained, and that the disappearance of GH response to TRH probably indicates satisfactory treatment of acromegaly. These data suggest that the 'paradoxical' GH responses frequently found in acromegaly are dependent on the adenoma per se and not on hypothalamic dysfunction.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 417883     DOI: 10.1111/j.1365-2265.1978.tb02171.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

1.  Assessment of pituitary function.

Authors:  T D Hockaday
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-10

2.  Recent developments in the treatment of acromegaly.

Authors:  D K Lüdecke
Journal:  Neurosurg Rev       Date:  1985       Impact factor: 3.042

3.  The influence of diabetes mellitus on thyrotropin response to thyrotropin-releasing hormone in untreated acromegalic patients.

Authors:  C Shigemasa; K Abe; S Taniguchi; Y Mitani; Y Ueta; T Adachi; K Urabe; T Tanaka; A Yoshida; T Hori
Journal:  J Endocrinol Invest       Date:  1988-04       Impact factor: 4.256

4.  Surgical therapy of lesions within the hypothalamic region.

Authors:  R Fahlbusch; U Schrell
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

Review 5.  Recent developments in acromegaly: a review.

Authors:  A Jadresic
Journal:  J R Soc Med       Date:  1983-11       Impact factor: 18.000

6.  Investigation of responsiveness to thyrotropin-releasing hormone in growth hormone-producing pituitary adenomas.

Authors:  Sang Ouk Chin; Sang Youl Rhee; Suk Chon; You-Cheol Hwang; In-Kyung Jeong; Seungjoon Oh; Sung-Woon Kim
Journal:  Int J Endocrinol       Date:  2013-11-21       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.